Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo

(2019) Brian H. White et al.   JOURNAL OF MEDICINAL CHEMISTRY

Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer

(2019) Kerry A. Whalen et al.   MOLECULAR CANCER THERAPEUTICS

68Ga-DOTATATE PET/CT Reveals Epstein-Barr Virus–Associated Nasopharyngeal Carcinoma in a Case of Suspected Sphenoid Wing Meningioma

(2018) Marcus Unterrainer et al.   CLINICAL NUCLEAR MEDICINE

Nerve Growth Factor (NGF)—Receptor Survival Axis in Head and Neck Squamous Cell Carcinoma

(2018) József Dudás et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Activation of SREBP1-mediated lipogenesis by the Epstein-Barr Virus-encoded LMP1 promotes cell proliferation and progression of nasopharyngeal carcinoma

(2018) Angela Kwok-Fung Lo et al.   JOURNAL OF PATHOLOGY

First in human phase 1/2a study of PEN-221 somatostatin analog (SSA)-DM1 conjugate for patients (PTS) with advanced neuroendocrine tumor (NET) or small cell lung cancer (SCLC): Phase 1 results.

(2018) Melissa Lynne Johnson et al.   JOURNAL OF CLINICAL ONCOLOGY

Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma

(2018) Weitao Lin et al.   Nature Communications

Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma

(2017) Jason W Chan et al.   Future Oncology

Genomic Analysis of Nasopharyngeal Carcinoma Reveals TME-Based Subtypes

(2017) Li Zhang et al.   MOLECULAR CANCER RESEARCH

Salmon provides fast and bias-aware quantification of transcript expression

(2017) Rob Patro et al.   NATURE METHODS

The Reactome Pathway Knowledgebase

(2017) Antonio Fabregat et al.   NUCLEIC ACIDS RESEARCH

Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations

(2017) Yvonne Y Li et al.   Nature Communications

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

(2016) Li Zhang et al.   LANCET

Nasopharyngeal carcinoma

(2016) Melvin L K Chua et al.   LANCET

68Ga-DOTA-peptide: A novel molecular biomarker for nasopharyngeal carcinoma

(2015) Lih Kin Khor et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

limma powers differential expression analyses for RNA-sequencing and microarray studies

(2015) Matthew E. Ritchie et al.   NUCLEIC ACIDS RESEARCH

68Ga-DOTA0-Tyr3-octreotide positron emission tomography in nasopharyngeal carcinoma

(2014) Volker H. Schartinger et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Nodal metastasis and survival in oral cancer: Association with protein expression of SLPI, not with LCN2, TACSTD2, or THBS2

(2014) Rob Noorlag et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Preparation of Compact Agarose Cell Blocks from the Residues of Liquid-Based Cytology Samples

(2014) Suk Jin Choi et al.   Korean Journal of Pathology

Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

(2014) Martyn E. Caplin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Etiological factors of nasopharyngeal carcinoma

(2014) Sai Wah Tsao et al.   ORAL ONCOLOGY

Constitutive activation of distinct NF-κB signals in EBV-associated nasopharyngeal carcinoma

(2013) Grace Tin-Yun Chung et al.   JOURNAL OF PATHOLOGY

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

(2012) Guangchuang Yu et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Genetic predisposition factors and nasopharyngeal carcinoma risk: A review of epidemiological association studies, 2000–2011

(2012) Allan Hildesheim et al.   SEMINARS IN CANCER BIOLOGY

A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma

(2011) Benoit You et al.   AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS

Somatostatin and somatostatin receptors: implications for neoplastic growth and cancer biology

(2009) Pavlos Msaouel et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS